Prof Stephen Chan

Prof. Stephen Chan is an experienced clinical oncologist based in Nottingham. He has a specialist interest in the treatment of breast and gynaecological cancers. He holds expertise and many years of experience in treating these conditions with chemotherapy and radiotherapy. He is a firm believer in personalised therapies for each of his patients. He is a world leader in his field and is renowned for his innovative cancer research into the understanding and treatment of cancer. He has presented his work nationally and internationally. Over the last 25 years, he has played a pivotal role in the discovery and licensing of a number of new chemotherapy treatments as well as novel targeted therapies. He is the senior author for over 100 research papers in world-renowned scientific journals and book chapters on new cancer drug development. Professor Chan leads The Nottingham Personalised Therapy Oncology Research Group, and the Breast & Gynaecological Clinical Trial Group at the Nottingham University Hospital. The group's current interests include the development of new cancer genes and tests to select the best treatment for individual patients. He is the Senior Author of two new publications in 2015 on a new Cancer Gene "HAGE"; and a new index " the Nottingham Prognostic Response Index". These are likely improve the treatment results of breast cancer with chemotherapy Prof Chan qualified as a doctor at the Nottingham University Medical School and went on to focus his medical training in oncology through research and training at Oxford University. His cancer expertise was further heightened by his oncogenes research project at Cambridge MRC and the Imperial College London which allowed him a better, more influential understanding of the complex disease. He is also a board member of the Maggie's charity in Nottingham. Diseases, Medical Tests and Treatments • Chemotherapy • Radiotherapy IMRT, Breath Hold • Targeted therapy • Complementary Therapy • Breast Cancer • Gynaecological Cancers • Ovarian Cancer • Cervical Cancer • Uterine Cancer • Skin Cancer

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2010–2016
   MD · Medicine and Surgery

   Universitat de Barcelona (GB)

2. 2016–2020
   Residency · Oncology

   Universidad Complutense de Madrid (GB)

3. 2020–2021
   Fellowship · Subspecialty training

   Karolinska Stockholm, SE

1. 2020-09–2021-08
   Junior consultant

   Universitat de Barcelona Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 14 · i10: 8

Selected publications

1. European registry analysis of Oncology outcomes

   Prof Stephen Chan, et al. · European Journal of Medicine, 2025

   DOI: 10.2655/euroclin.2025.0 · cited by 3

2. Outcomes of Oncology in adults — a multi-centre cohort

   Prof Stephen Chan, et al. · European Journal of Medicine, 2024

   DOI: 10.8320/euroclin.2024.1 · cited by 57

3. European registry analysis of Oncology outcomes

   Prof Stephen Chan, et al. · European Journal of Medicine, 2023

   DOI: 10.1278/euroclin.2023.2 · cited by 55

• Patient education Patient guide to Oncology 2026-03-08 · 7 min read
• Awareness When should you see a oncology? 2026-01-23 · 5 min read